Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 02, 2023

SELL
$2.88 - $8.8 $31,253 - $95,497
-10,852 Reduced 17.19%
52,266 $176,000
Q2 2023

Aug 09, 2023

BUY
$7.46 - $10.67 $58,575 - $83,780
7,852 Added 14.21%
63,118 $522,000
Q1 2023

May 11, 2023

SELL
$8.44 - $13.35 $158,064 - $250,018
-18,728 Reduced 25.31%
55,266 $483,000
Q4 2022

Feb 13, 2023

BUY
$5.58 - $13.94 $197,554 - $493,531
35,404 Added 91.74%
73,994 $903,000
Q4 2022

Feb 13, 2023

SELL
$5.58 - $13.94 $233,601 - $583,584
-41,864 Reduced 52.03%
38,590 $471,000
Q3 2022

Nov 14, 2022

BUY
$6.1 - $11.41 $71,418 - $133,588
11,708 Added 17.03%
80,454 $510,000
Q2 2022

Aug 05, 2022

BUY
$6.61 - $11.99 $454,411 - $824,264
68,746 New
68,746 $618,000
Q1 2022

May 09, 2022

SELL
$11.56 - $17.9 $150,834 - $233,559
-13,048 Closed
0 $0
Q4 2021

Feb 07, 2022

BUY
$17.36 - $27.36 $226,513 - $356,993
13,048 New
13,048 $229,000

Others Institutions Holding SGHT

About Sight Sciences, Inc.


  • Ticker SGHT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,826,200
  • Market Cap $175M
  • Description
  • Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; a...
More about SGHT
Track This Portfolio

Track M&T Bank Corp Portfolio

Follow M&T Bank Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

News

Stay updated on M&T Bank Corp with notifications on news.